ArticleMolecular psychiatry2026
Retinal cytoarchitectural alterations across the psychosis spectrum and their correlates with cognition: a UK biobank nested case-control study.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Further Evidence Is Needed to Support the Perceptual Theory of Schizophrenia.Biological psychiatry global open science · 2026Article
- The eye as a canary in the coal mine: oculomics for psychiatry.Molecular psychiatry · 2026Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Retinal structure may serve as a biomarker for psychosis-spectrum disorders (PSD) and cognition, but larger, well-controlled and detailed studies are needed. This study investigates retinal thickness differences and their association with cognition in PSD (including schizophrenia, bipolar disorder, and major depression with psychosis) compared to age-, sex-matched healthy controls (HC). In this nested case-control study using the UK Biobank data, 476 participants underwent macular optical coherence tomography (OCT). Repeated-measures ANCOVA assessed retinal thickness across two measures (left/right eyes) and two groups (PSD/HC). Comprehensive analyses were conducted, accounting for various sociodemographic (ethnicity, area-level deprivation, etc); ocular (visual acuity, intraocular pressure, etc); and health (blood pressure, body mass index) covariates, as well as excluding individuals with cardiometabolic conditions. Layers were evaluated to determine their relationship with cognition. Thinner maculae (F = 23.02, η²p = 0.05, p < 0.001), ganglion cell-inner plexiform (F = 6.42, η²p = 0.01, p = 0.043) and photoreceptor layers (F = 35.31, η²p = 0.07, p < 0.001) were identified in PSD. The macular nerve fiber, inner nuclear, and retinal pigment epithelium layers appeared unaffected. Furthermore, smaller photoreceptor layer thickness was associated with poorer prospective memory performance (ß=0.12, B = 2.15, 95% CI [0.39, 3.92], p = 0.017). The schizophrenia (F = 26.84, η²p = 0.07, p < 0.001) and bipolar disorder (F = 16.60, η²p = 0.05, p = 0.006) groups demonstrated the greatest as well as overlapping alterations in the photoreceptor layers. Individuals with PSD exhibit synaptic, ganglion-cell, and photoreceptor structural alterations with ocular and health-related factors -particularly cardiometabolic disorders- likely contributing to these changes. In an exploratory analysis, changes in photoreceptor morphology in PSD might be related to neurobiological mechanisms associated with visual processing and memory deficits.
Indexed as
Identifiers
41241666What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.